Cargando…
Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic
Background: The purpose of this study was to characterize the novel sedative/hypnotic agent HSK3486, a 2,6-disubstituted alkylphenol analogue. Methods: The mechanism of action of HSK3486 was studied in competitive binding assays and whole-cell patch clamp assays. HSK3486 was administered by bolus in...
Autores principales: | Liao, Juan, Li, Meiting, Huang, Chaoli, Yu, Yan, Chen, Yashu, Gan, Jiaqi, Xiao, Jie, Xiang, Guilin, Ding, Xizhi, Jiang, Rong, Li, Peng, Yang, Mengchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851058/ https://www.ncbi.nlm.nih.gov/pubmed/35185584 http://dx.doi.org/10.3389/fphar.2022.830791 |
Ejemplares similares
-
Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment
por: Hu, Yue, et al.
Publicado: (2022) -
Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly
por: Li, Xiaojiao, et al.
Publicado: (2021) -
A systematic review and meta-analysis comparing the efficacy and safety of ciprofol (HSK3486) versus propofol for anesthetic induction and non-ICU sedation
por: Hung, Kuo-Chuan, et al.
Publicado: (2023) -
Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study
por: Luo, Zhen, et al.
Publicado: (2022) -
Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi‐centre, non‐inferiority, randomized, controlled phase 3 clinical trial
por: Li, Junxiang, et al.
Publicado: (2022)